Target intelligence / Profile preview

Src kinase-associated phosphoprotein 2 (SKAP2)

Target
SKAP2
Molecular classification
Adaptor protein (binds other signaling molecules via specific interaction domains), Other (does not fit classical categories such as receptor, enzyme, or ion channel)
01

Overview

SKAP2 (Src kinase-associated phosphoprotein 2) is an adaptor protein predominantly expressed in hematopoietic cells, including neutrophils, macrophages, and B cells. It contains three functional domains: a dimerization domain (DM) promoting self-association, a pleckstrin homology (PH) domain for lipid/membrane interactions, and an SH3 domain for binding Src family kinases and other interactors. SKAP2 regulates integrin-mediated actin cytoskeleton rearrangement and cluster formation, controlling adhesive and effector functions such as phagocytosis, reactive oxygen species (ROS) generation, and antibody-dependent cellular cytotoxicity (ADCC) in immune cells. Loss or deficiency of SKAP2 impairs these effector responses. SKAP2 is also implicated in inhibition of tumor invasiveness and modulation of signal transduction pathways relevant to cancer and inflammatory disease. While SKAP2 has no known direct drug, its role in immune signaling makes it a candidate for further therapeutic exploration.

Other names
Src kinase-associated phosphoprotein 2SKAP2PRAPRA70SAPSSCAP2SKAP-55HOMSKAP55RSKAP-HOMSKAP55 homologPyk2/RAFTK-associated proteinRetinoic acid-induced protein 70Src family-associated phosphoprotein 2Src kinase-associated phosphoprotein of 55-related proteinSrc-associated adapter protein with PH and SH3 domainsFyn-associated phosphoprotein SKAP55 homologue
02

Mechanism of action

None assigned directly; as there are no approved drugs specifically targeting SKAP2, assigned mechanisms are theoretical and would relate to interruption/modulation of adaptor-mediated immune signaling.

03

Biological functions

Regulation of actin polymerizationSignal transduction (integrin-mediated)Immune response activationCell adhesionCytoskeletal rearrangementPhagocytosisReactive oxygen species (ROS) productionAntibody-dependent cellular cytotoxicity (ADCC)
04

Disease associations

Cancer (implicated in tumor invasiveness and immune cell cytotoxicity)Inflammation (modulates neutrophil and macrophage effector responses)Infection (role in neutrophil killing of bacteria and fungi, associated with oral candidiasis)Potential relevance in neurodegenerative disease via regulation of alpha-synuclein phosphorylation
05

Safety considerations

Potential for immune suppression or dysregulation if broadly inhibited, due to SKAP2’s role in neutrophil and macrophage effector functionsPossible off-target cytoskeletal or adhesion effectsNo specific safety data, as no direct SKAP2 inhibitor is in clinical use.
06

Interacting drugs

None identified directly; no well-established small molecule drugs or biologics are known to specifically target SKAP2. Therapeutic modulation would likely be indirect, for example via upstream or downstream effectors (such as integrins, Syk, Fyn, or Pyk2/RAFTK).
07

Biomarkers

None established for clinical use; SKAP2 has potential as a biomarker of immune cell activation and neutrophil/macrophage function in cancer and inflammatory disease, but not currently used clinically.

Beyond the preview

Go deeper on Src kinase-associated phosphoprotein 2 (SKAP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Src kinase-associated phosphoprotein 2 (SKAP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call